ARNULFO B BONAVENTE

Allopathic & Osteopathic Physicians|Family Medicine UPPER MARLBORO, MD NPI 1619973534

General Payments — all program years on this page

$605.19

  • Category: General Payments
  • Program years: PY2018–2020
  • Record count: 28
  • As of (CMS publication): 2026-01-23

Latest program year (PY2020): $419.39 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2020) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $419.3922

By paying entity

Latest program year (PY2020) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $11.901
2019 $173.905
2020 $419.3922

Records — PY2020 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
723393547 Allergan, Inc. $14.36 09/18/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
735780597 AstraZeneca Pharmaceuticals LP $20.02 07/08/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
735887405 AstraZeneca Pharmaceuticals LP $12.13 06/15/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
735972177 AstraZeneca Pharmaceuticals LP $16.59 05/28/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736064471 AstraZeneca Pharmaceuticals LP $18.66 09/15/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736093581 AstraZeneca Pharmaceuticals LP $20.01 06/18/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736111233 AstraZeneca Pharmaceuticals LP $16.39 04/22/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736190477 AstraZeneca Pharmaceuticals LP $19.63 10/21/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736389721 AstraZeneca Pharmaceuticals LP $21.05 02/11/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
737185093 Esperion Therapeutics, Inc. $22.68 09/23/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
738820271 GlaxoSmithKline, LLC. $18.90 07/06/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
739797359 Amarin Pharma Inc. $21.19 01/30/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
740917469 Amgen Inc. $27.88 04/23/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
740917473 Amgen Inc. $21.36 02/20/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
740917475 Amgen Inc. $25.42 05/19/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
743785831 PFIZER INC. $20.98 10/01/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
744617381 Novo Nordisk Inc $17.91 02/03/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
744786323 Novo Nordisk Inc $17.89 06/09/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
747634957 Merck Sharp & Dohme Corporation $14.57 07/16/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
747715087 Merck Sharp & Dohme Corporation $12.95 06/03/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
747955529 Gilead Sciences, Inc. $15.60 05/26/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
751216407 Eisai Inc. $23.22 08/07/2020 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.